Literature DB >> 10494710

Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre-screening tool for studies.

A Wolkerstorfer1, F B de Waard van der Spek, E J Glazenburg, P G Mulder, A P Oranje.   

Abstract

Different scoring systems have been developed to determine the severity of atopic dermatitis. The SCORAD (SCORing Atopic Dermatitis), one of the best validated systems, is suited for clinical trials, but is too complicated and time consuming for routine clinical use. The TIS score (Three Item Severity score), a simplified system, is based on the evaluation of erythema, oedema/papulation and excoriation on a scale from 0 to 3. In order to determine the value of the TIS score we conducted a prospective study in 126 children with mild to severe atopic dermatitis. Both the TIS score and the SCORAD were assessed by trained investigators. Interobserver agreement was investigated in 20 children by comparing the independently performed scores of three investigators. A positive correlation was found between the TIS score and the SCORAD (Rank Spearman r(s)=0.86; p<0.0005). The item which correlated best with the SCORAD was excoriation (r(s)=0.72; p<0.0005) followed by oedema/papulations (r(s)=0.66; p<0.0005). Interobserver agreement which was calculated by Cohen's kappa (kappa) was "excellent" for SCORAD (kappa=0.82; p<0.001) and "fair" for TIS score (kappa=0.58; p<0.01). We conclude that the TIS score is a rough, though reliable and simple system for scoring atopic dermatitis. It is particularly suitable in general practice, for routine clinical use and for screening purposes in clinical trials. For research purposes, the objective SCORAD offers a more detailed and comprehensive assessment.

Entities:  

Mesh:

Year:  1999        PMID: 10494710     DOI: 10.1080/000155599750010256

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  36 in total

1.  Altered peripheral invariant natural killer T cells in atopic dermatitis.

Authors:  Edit Gyimesi; Georgina Nagy; Éva Remenyik; Sándor Sipka; Margit Zeher; Tamás Bíró; Andrea Szegedi
Journal:  J Clin Immunol       Date:  2011-06-21       Impact factor: 8.317

2.  Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy.

Authors:  Sjors A Koppes; Richard Brans; Suzana Ljubojevic Hadzavdic; Monique H W Frings-Dresen; Thomas Rustemeyer; Sanja Kezic
Journal:  Int Arch Allergy Immunol       Date:  2016-09-02       Impact factor: 2.749

3.  The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures.

Authors:  Thaschawee Arkachaisri; Soamarat Vilaiyuk; Suzanne Li; Kathleen M O'Neil; Elena Pope; Gloria C Higgins; Marilynn Punaro; Egla C Rabinovich; Margalit Rosenkranz; Daniel A Kietz; Paul Rosen; Steven J Spalding; Teresa R Hennon; Kathryn S Torok; Elaine Cassidy; Thomas A Medsger
Journal:  J Rheumatol       Date:  2009-10-15       Impact factor: 4.666

4.  Determining the severity of atopic dermatitis in children presenting in general practice: an easy and fast method.

Authors:  Marjolein G Willemsen; Rosalinda W C van Valburg; Pauline C Dirven-Meijer; Arnold P Oranje; Johannes C van der Wouden; Heleen Moed
Journal:  Dermatol Res Pract       Date:  2009-11-18

Review 5.  Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

Authors:  Lawrence F Eichenfield; Wynnis L Tom; Sarah L Chamlin; Steven R Feldman; Jon M Hanifin; Eric L Simpson; Timothy G Berger; James N Bergman; David E Cohen; Kevin D Cooper; Kelly M Cordoro; Dawn M Davis; Alfons Krol; David J Margolis; Amy S Paller; Kathryn Schwarzenberger; Robert A Silverman; Hywel C Williams; Craig A Elmets; Julie Block; Christopher G Harrod; Wendy Smith Begolka; Robert Sidbury
Journal:  J Am Acad Dermatol       Date:  2013-11-27       Impact factor: 11.527

6.  Asthma in patients with atopic dermatitis.

Authors:  Z Pourpak; H Mozaffari; M Gharagozlou; Z Daneshmandi; M Moin
Journal:  Indian J Pediatr       Date:  2008-02       Impact factor: 1.967

7.  Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study.

Authors:  John Berth-Jones; Robert J Damstra; Stefan Golsch; John K Livden; Oliver Van Hooteghem; Fulvio Allegra; Christine A Parker
Journal:  BMJ       Date:  2003-06-21

8.  Filaggrin null mutations and childhood atopic eczema: a population-based case-control study.

Authors:  Sara J Brown; Caroline L Relton; Haihui Liao; Yiwei Zhao; Aileen Sandilands; Ian J Wilson; John Burn; Nick J Reynolds; W H Irwin McLean; Heather J Cordell
Journal:  J Allergy Clin Immunol       Date:  2008-03-04       Impact factor: 10.793

9.  Skin Reaction Report Form: Development and Design of a Standardized Report Form for Skin Reactions Due to Medical Devices for Diabetes Management.

Authors:  Guido Freckmann; Sina Buck; Delia Waldenmaier; Eva Zschornack; Manuela Link; Nina Jendrike; Ines Obstfelder; Sara Vetrugno; Stefanie Kamann; Cornelia Haug
Journal:  J Diabetes Sci Technol       Date:  2020-03-22

10.  Filaggrin haploinsufficiency is highly penetrant and is associated with increased severity of eczema: further delineation of the skin phenotype in a prospective epidemiological study of 792 school children.

Authors:  S J Brown; C L Relton; H Liao; Y Zhao; A Sandilands; W H I McLean; H J Cordell; N J Reynolds
Journal:  Br J Dermatol       Date:  2009-06-11       Impact factor: 9.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.